Chromocell Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
September 01, 2023 at 04:59 pm EDT
Chromocell Therapeutics Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 0.953347 million compared to USD 0.334056 million a year ago. Basic loss per share from continuing operations was USD 0.9.
For the six months, net loss was USD 1.92 million compared to USD 0.644506 million a year ago. Basic loss per share from continuing operations was USD 1.8.